Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose hydrocortisone for severe A/H1N1 2009 influenza pneumonia
2009-016945-24Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Influenza A(H1N1)pdm09 pneumonia comparing Hydrocortisone plus antiviral therapy with Placebo plus antiviral therapy (2 arms). Primary endpoint: Hospital mortality. Started Nov 2009; status: active.
02
Drugs
hydrocortisone
03
Conditions
Influenza A(H1N1)pdm09 pneumonia
Beyond the preview
Go deeper on 2009-016945-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016945-24.